Student id- 104342405 Muskan SWIN BUR NE SWINBURNE UNIVERSITY OF · TECHNOLOGY INF20029- Digital Business Analysis and Design 2023 Semester 2 Assignment 1 (individual): Current System Analysis and Modelling Name: Muskan Student Id .: 104342405 1 Swinburne University Of technology
Student id- 104342405 Muskan SWIN BUR * NE * SWINBURNE UNIVERSITY OF . TECHNOLOGY Part A: Q-1. LGM's Stakeholders LGM Stakeholders: LGM (Live Glucose Monitoring) engages a wide spectrum of individuals and entities, which include: • Patients: Patients occupy a central role in the LGM context and should actively participate in shaping system requirements. Their insights into usability, comfort, and specific health needs hold immense value, ultimately bolstering user acceptance and the overall efficacy of the device. · Healthcare Professionals: Beyond physicians, various healthcare practitioners, such as nurses, caregivers, and specialists, assume pivotal functions in diabetes care. Collaborating with this diverse group is strongly recommended due to their contributions to comprehensive patient care, timely interventions, and seamless integration into healthcare workflows. . BioMed Healthcare Equipment: As the manufacturer of the device, BioMed assumes a central position. Ensuring alignment with the preferences and requirements of patients and healthcare providers is of utmost importance to maintain the device's relevance and success. . My Health Medical Centers: My Health plays a crucial role as a partner in the LGM ecosystem. The functionality, precision, and integration of LGM data into their healthcare systems are of paramount significance. · Regulatory Authorities: Regulatory bodies oversee healthcare technologies, ensuring compliance with standards and data privacy regulations. Their involvement is pivotal for obtaining product approval and adhering to regulatory guidelines. · Insurance Companies: Insurers may express interest in comprehending the device's impact on patient outcomes and long-term healthcare costs, rendering them pertinent stakeholders. Patient Involvement in System Requirements: Actively engaging patients in the formulation of system requirements is not merely advisable but essential. Patient experiences yield profound insights into practicality, ease of use, and daily integration. Patient input serves to enhance user-centric design and acceptance, ultimately contributing to enhanced health outcomes. Interaction with Medical Professionals Beyond Physicians: Indeed, LGM should foster collaboration with healthcare professionals extending beyond physicians. Nurses, caregivers, and specialists play pivotal roles in diabetes care, offering holistic support, timely interventions, and seamless integration into healthcare workflows. This collaboration amplifies the device's impact on patient outcomes and ensures the delivery of comprehensive healthcare. 2 Swinburne University Of technology
Student id- 104342405 Muskan Q-2. Requirements and Questions: As the lead analyst for LGM, determining requirements is a critical task that involves gathering detailed information and insights. To do this, I would ask the following clear and concise questions: 1. Understanding User Monitoring Frequency: · Question: How often should users check their glucose levels? · Reason: Gaining insights into monitoring frequency is pivotal for shaping the device's functionality and data management to align with user expectations. 2. Enhancing Healthcare Professional Collaboration: · Question: What features could improve the ability of healthcare professionals to provide better care? · Reason: Engaging with healthcare experts aids in pinpointing essential functionalities required